These trials are currently being conducted. Lacripep trials are geared specifically toward sjogrens patients. Please go to website and see if there's a city near you. You must be ssa or ssb positive or lip biopsy positive. I have a trial site about 2 hours from me but I do not qualify due to negative ssa and ssb , my diagnosis came from early sjo test by immco labs. I hope this helps us out. Been praying for some relief. Anybody else heard of these trials?
I am actually starting this trial.
The criteria requires positive lip biopsy OR positive for SS-A/B antibodies, but not necessarily both like other trials.
TearsSolutions is the developer and they have a Facebook webpage detailing the science/rigor behind Lacritin, and info about the some 25 trial sites.
Highly recommend folks here look into this... it is low risk, as Lacritin is a natural protein already occurring in the tear film biome.
Has anyone else frequenting this forum been able to participate in this trial, or am I the only one?
I still highly encourage folks here to approach Tearsolutions directly about participating in the trial via their facebook page.
https://tearsolutions.com/
https://news.virginia.edu/content/new-dry-eye-drug-first-aims-treat-cause-rather-symptoms?amp
https://clinicaltrials.gov/ct2/show/study/NCT03226444?show_locs=Y#locn
Informative videos about the technical rigor behind the discovery/development of Lacripep:
https://www.facebook.com/LacritinAndDryEye/videos/vb.1376039919276146/2025710027642462/?type=2&theater
https://www.facebook.com/LacritinAndDryEye/videos/vb.1376039919276146/2002993679914097/?type=2&theater
Very excited to share this update on the Phase-I/II trial of Lacripep in Sjogerns Dry-Eye, reference the link below for the Facebook post/media release from TearSolutions:
https://m.facebook.com/LacritinAndDryEye/
I participated in the trial and received it for a while via FDA Expanded Access for Investigational New Drug (IND). The stuff is a God send, particularly for my clinical picture.
Post away :) Finally some uniquely good trial news for us.